Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03380091 · ClinicalTrials.gov registry record · Phase 4
Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial
A Phase 4 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03380091 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 5 participants.
The verdict
NCT03380091, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Open-label randomized clinical trial assessing the efficacy of Metformin versus Vitamin D in improving symptoms of depressed mood in polycystic ovary syndrome.
Interventions
- DRUG Metformin
- DRUG Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2019-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03380091
The ClinicalTrials.gov registry entry for NCT03380091 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT03380091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03380091 about?
NCT03380091 is a clinical study titled "Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial". Open-label randomized clinical trial assessing the efficacy of Metformin versus Vitamin D in improving symptoms of depressed mood in polycystic ovary syndrome.
What is the current status of trial NCT03380091?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2017-12-12. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT03380091?
The interventions under investigation include: Metformin (DRUG), Vitamin D (DRUG).
Who is sponsoring clinical trial NCT03380091?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.